Charles River (NYSE: CRL) insider sells 2,039 shares in 10b5-1 plan
Rhea-AI Filing Summary
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) executive Shannon M. Parisotto, CEVP, Discovery & Safety Assessment, reported an option exercise-and-sale transaction. Parisotto exercised 2,039 stock options at an exercise price of $194.12 per share, acquiring 2,039 common shares, and then sold 2,039 common shares at $294.12 per share. The sale was made pursuant to a Rule 10b5-1 Trading Plan initially adopted on March 4, 2026. Following these transactions, Parisotto reports indirect ownership of 9,680 common shares by a trust and 28,510 common shares through Karpathos Investments LLC, as shown in the holding entries.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 2,039 shares ($204K approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
Parisotto Shannon M
Role
CEVP, Disc & Safety Assessment
Sold
2,039 shs ($600K)
Approx. gross sale proceeds
$600K
Approx. exercise cost
$396K
Approx. pre-tax spread
$204K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) | 2,039 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,039 | $194.12 | $396K |
| Sale | Common Stock F1 | 2,039 | $294.12 | $600K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 2,039 shares (Direct);
Common Stock — 4,807 shares (Direct);
Common Stock — 9,680 shares (Indirect, By Trust);
Common Stock — 28,510 shares (Indirect, by Karpathos Investments LLC)
Footnotes (1)
- F1. This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026.
Key Figures
Options exercised: 2,039 shares
Exercise price: $194.12 per share
Sale price: $294.12 per share
+5 more
8 metrics
Options exercised
2,039 shares
Stock options (right to buy) exercised into common stock
Exercise price
$194.12 per share
Exercise price of stock options for 2,039 shares
Sale price
$294.12 per share
Sale of 2,039 common shares
Shares sold
2,039 shares
Common stock sold following option exercise
Indirect holdings by trust
9,680 shares
Common stock held indirectly, "By Trust" after reported transactions
Indirect holdings via Karpathos Investments LLC
28,510 shares
Common stock held indirectly through Karpathos Investments LLC
Option expiration date
May 26, 2033
Expiration date of the stock options exercised for 2,039 shares
Net buy/sell shares
-2,039 shares
Net shares sold across reported buy/sell transactions
Key Terms
Rule 10b5-1 Trading Plan, Stock Options (Right to Buy), indirect ownership, exercise or conversion of derivative security
4 terms
Rule 10b5-1 Trading Plan regulatory
"This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Options (Right to Buy) financial
"security_title": "Stock Options (Right to Buy)""
indirect ownership financial
"ownership_type": "indirect", "nature_of_ownership": "By Trust""
exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
FAQ
What insider transactions did CRL executive Shannon M. Parisotto report on this Form 4?
Shannon M. Parisotto reported exercising 2,039 stock options at $194.12 per share, receiving 2,039 common shares, and then selling 2,039 common shares at $294.12 per share in CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
Were Shannon M. Parisotto’s CRL stock transactions under a Rule 10b5-1 plan?
Yes. The filing states that the exercise and sale of 2,039 CRL common shares occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026.
What is the exercise and expiration timeline for the CRL stock options involved?
The stock options exercised for 2,039 shares of CRL common stock have an exercise (or vesting) date of May 26, 2024 and an expiration date of May 26, 2033, with an exercise price of $194.12 per share.
What is Shannon M. Parisotto’s role at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)?
Shannon M. Parisotto is reported as an officer of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) with the title CEVP, Discovery & Safety Assessment on this Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
